{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:09Z","timestamp":1792784829391,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH Intramural Research Program of the NIAMS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41375-019-0656-9","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T14:02:17Z","timestamp":1574690537000},"page":"1354-1363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1"],"prefix":"10.1038","volume":"34","author":[{"given":"Irina A.","family":"Elcheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Chiarolanzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Chim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chethana P.","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4336-6518","authenticated-orcid":false,"given":"Markus","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinisa","family":"Dovat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-446X","authenticated-orcid":false,"given":"Stefan A.","family":"Muljo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir S.","family":"Spiegelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"656_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941\u201353.","journal-title":"Int J Cancer"},{"key":"656_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/jcm4010127","volume":"4","author":"JD de Rooij","year":"2015","unstructured":"de Rooij JD, Zwaan CM, van den Heuvel-Eibrink M. Pediatric AML: from biology to clinical management. J Clin Med. 2015;4:127\u201349.","journal-title":"J Clin Med"},{"key":"656_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424\u201347.","journal-title":"Blood"},{"key":"656_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0125-0","volume":"8","author":"JC Hernandez-Boluda","year":"2018","unstructured":"Hernandez-Boluda JC, Pereira A, Pastor-Galan I, Alvarez-Larran A, Savchuk A, Puerta JM, et al. Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients. Blood Cancer J. 2018;8:91.","journal-title":"Blood Cancer J"},{"key":"656_CR5","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730\u20137.","journal-title":"Nat Med"},{"key":"656_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","volume":"547","author":"LI Shlush","year":"2017","unstructured":"Shlush LI, Mitchell A, Heisler L, Abelson S, Ng SWK, Trotman-Grant A, et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature. 2017;547:104\u20138.","journal-title":"Nature"},{"key":"656_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SW Ng","year":"2016","unstructured":"Ng SW, Mitchell A, Kennedy JA, Chen WC, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433\u20137.","journal-title":"Nature"},{"key":"656_CR8","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1101\/gad.287540.116","volume":"30","author":"N Degrauwe","year":"2016","unstructured":"Degrauwe N, Suva ML, Janiszewska M, Riggi N, Stamenkovic I. IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer. Genes Dev. 2016;30:2459\u201374.","journal-title":"Genes Dev"},{"key":"656_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13045-018-0628-y","volume":"11","author":"X Huang","year":"2018","unstructured":"Huang X, Zhang H, Guo X, Zhu Z, Cai H, Kong X. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer. J Hematol Oncol. 2018;11:88.","journal-title":"J Hematol Oncol"},{"key":"656_CR10","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1172\/JCI80046","volume":"126","author":"JK Palanichamy","year":"2016","unstructured":"Palanichamy JK, Tran TM, Howard JM, Contreras JR, Fernando TR, Sterne-Weiler T, et al. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. J Clin Investig. 2016;126:1495\u2013511.","journal-title":"J Clin Investig"},{"key":"656_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13045-017-0507-y","volume":"10","author":"J Zhou","year":"2017","unstructured":"Zhou J, Bi C, Ching YQ, Chooi JY, Lu X, Quah JY, et al. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia. J Hematol Oncol. 2017;10:138.","journal-title":"J Hematol Oncol"},{"key":"656_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1080\/19491034.2017.1285989","volume":"8","author":"DB Mark Welch","year":"2017","unstructured":"Mark Welch DB, Jauch A, Langowski J, Olins AL, Olins DE. Transcriptomes reflect the phenotypes of undifferentiated, granulocyte and macrophage forms of HL-60\/S4 cells. Nucleus. 2017;8:222\u201337.","journal-title":"Nucleus"},{"key":"656_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1006\/excr.1998.4210","volume":"245","author":"AL Olins","year":"1998","unstructured":"Olins AL, Buendia B, Herrmann H, Lichter P, Olins DE. Retinoic acid induction of nuclear envelope-limited chromatin sheets in HL-60. Exp Cell Res. 1998;245:91\u2013104.","journal-title":"Exp Cell Res"},{"key":"656_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.tranon.2017.07.008","volume":"10","author":"L Mahapatra","year":"2017","unstructured":"Mahapatra L, Andruska N, Mao C, Le J, Shapiro DJ. A novel IMP1 inhibitor, BTYNB, targets c-Myc and inhibits melanoma and ovarian cancer cell proliferation. Transl Oncol. 2017;10:818\u201327.","journal-title":"Transl Oncol"},{"key":"656_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/sj.onc.1201093","volume":"14","author":"P Leeds","year":"1997","unstructured":"Leeds P, Kren BT, Boylan JM, Betz NA, Steer CJ, Gruppuso PA, et al. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro. Oncogene. 1997;14:1279\u201386.","journal-title":"Oncogene"},{"key":"656_CR16","doi-asserted-by":"publisher","first-page":"29562","DOI":"10.1074\/jbc.M001156200","volume":"275","author":"S Runge","year":"2000","unstructured":"Runge S, Nielsen FC, Nielsen J, Lykke-Andersen J, Wewer UM, Christiansen J. H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. J Biol Chem. 2000;275:29562\u20139.","journal-title":"J Biol Chem"},{"key":"656_CR17","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1093\/nar\/gkt410","volume":"41","author":"A Zirkel","year":"2013","unstructured":"Zirkel A, Lederer M, Stohr N, Pazaitis N, Huttelmaier S. IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG). Nucleic Acids Res. 2013;41:6618\u201336.","journal-title":"Nucleic Acids Res"},{"key":"656_CR18","doi-asserted-by":"crossref","unstructured":"Ghoshal A, Rodrigues LC, Gowda CP, Elcheva IA, Liu Z, Abraham T, et al. Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis. Oncogene. 2019;38:4182\u201396.","DOI":"10.1038\/s41388-019-0797-3"},{"key":"656_CR19","doi-asserted-by":"crossref","unstructured":"Rosenfeld YB, Krumbein M, Yeffet A, Schiffmann N, Mishalian I, Pikarsky E, et al. VICKZ1 enhances tumor progression and metastasis in lung adenocarcinomas in mice. Oncogene. 2019;38:4169\u201381.","DOI":"10.1038\/s41388-019-0715-8"},{"key":"656_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ijc.22716","volume":"121","author":"E Dimitriadis","year":"2007","unstructured":"Dimitriadis E, Trangas T, Milatos S, Foukas PG, Gioulbasanis I, Courtis N, et al. Expression of oncofetal RNA-binding protein CRD-BP\/IMP1 predicts clinical outcome in colon cancer. Int J Cancer. 2007;121:486\u201394.","journal-title":"Int J Cancer"},{"key":"656_CR21","doi-asserted-by":"publisher","first-page":"7584","DOI":"10.1038\/sj.onc.1210563","volume":"26","author":"M Kobel","year":"2007","unstructured":"Kobel M, Weidensdorfer D, Reinke C, Lederer M, Schmitt WD, Zeng K, et al. Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma. Oncogene. 2007;26:7584\u20139.","journal-title":"Oncogene"},{"key":"656_CR22","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1200\/JCO.2014.55.9880","volume":"33","author":"JL Bell","year":"2015","unstructured":"Bell JL, Turlapati R, Liu T, Schulte JH, Huttelmaier S. IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma. J Clin Oncol. 2015;33:1285\u201393.","journal-title":"J Clin Oncol"},{"key":"656_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.leukres.2016.05.009","volume":"47","author":"M Stoskus","year":"2016","unstructured":"Stoskus M, Eidukaite A, Griskevicius L. Defining the significance of IGF2BP1 overexpression in t(12;21)(p13;q22)-positive leukemia REH cells. Leuk Res. 2016;47:16\u201321.","journal-title":"Leuk Res"},{"key":"656_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bcmd.2011.02.005","volume":"46","author":"M Stoskus","year":"2011","unstructured":"Stoskus M, Gineikiene E, Valceckiene V, Valatkaite B, Pileckyte R, Griskevicius L. Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities. Blood Cells Mol Dis. 2011;46:321\u20136.","journal-title":"Blood Cells Mol Dis"},{"key":"656_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bcmd.2015.11.006","volume":"57","author":"M Stoskus","year":"2016","unstructured":"Stoskus M, Vaitkeviciene G, Eidukaite A, Griskevicius L. ETV6\/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia. Blood Cells Mol Dis. 2016;57:30\u20134.","journal-title":"Blood Cells Mol Dis"},{"key":"656_CR26","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1101\/gad.325100.119","volume":"33","author":"S Wang","year":"2019","unstructured":"Wang S, Chim B, Su Y, Khil P, Wong M, Wang X, et al. Enhancement of LIN28B-induced hematopoietic reprogramming by IGF2BP3. Genes Dev. 2019;33:1048\u201368.","journal-title":"Genes Dev"},{"key":"656_CR27","doi-asserted-by":"publisher","first-page":"E5664","DOI":"10.1073\/pnas.1609552114","volume":"114","author":"JF de Vasconcellos","year":"2017","unstructured":"de Vasconcellos JF, Tumburu L, Byrnes C, Lee YT, Xu PC, Li M, et al. IGF2BP1 overexpression causes fetal-like hemoglobin expression patterns in cultured human adult erythroblasts. Proc Natl Acad Sci USA. 2017;114:E5664\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"656_CR28","doi-asserted-by":"publisher","first-page":"48716","DOI":"10.1074\/jbc.M405853200","volume":"279","author":"B Liao","year":"2004","unstructured":"Liao B, Patel M, Hu Y, Charles S, Herrick DJ, Brewer G. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells. J Biol Chem. 2004;279:48716\u201324.","journal-title":"J Biol Chem"},{"key":"656_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1196\/annals.1349.014","volume":"1044","author":"C Abramovich","year":"2005","unstructured":"Abramovich C, Pineault N, Ohta H, Humphries RK. Hox genes: from leukemia to hematopoietic stem cell expansion. Ann NY Acad Sci. 2005;1044:109\u201316.","journal-title":"Ann N Y Acad Sci"},{"key":"656_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1179\/102453312X13376952196250","volume":"17","author":"S Umeda","year":"2012","unstructured":"Umeda S, Yamamoto K, Murayama T, Hidaka M, Kurata M, Ohshima T, et al. Prognostic significance of HOXB4 in de novo acute myeloid leukemia. Hematology. 2012;17:125\u201331.","journal-title":"Hematology"},{"key":"656_CR31","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1172\/JCI34371","volume":"118","author":"XB Zhang","year":"2008","unstructured":"Zhang XB, Beard BC, Trobridge GD, Wood BL, Sale GE, Sud R, et al. High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector. J Clin Investig. 2008;118:1502\u201310.","journal-title":"J Clin Investig"},{"key":"656_CR32","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3892\/ijo.2016.3738","volume":"49","author":"H Wang","year":"2016","unstructured":"Wang H, Jia XH, Chen JR, Yi YJ, Wang JY, Li YJ, et al. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562\/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K\/Akt signaling pathway. Int J Oncol. 2016;49:2529\u201337.","journal-title":"Int J Oncol"},{"key":"656_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10510-8","volume":"10","author":"M Kusakabe","year":"2019","unstructured":"Kusakabe M, Sun AC, Tyshchenko K, Wong R, Nanda A, Shanna C, et al. Synthetic modeling reveals HOXB genes are critical for the initiation and maintenance of human leukemia. Nat Commun. 2019;10:2913.","journal-title":"Nat Commun"},{"key":"656_CR34","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1126\/science.6585957","volume":"224","author":"PG Pelicci","year":"1984","unstructured":"Pelicci PG, Lanfrancone L, Brathwaite MD, Wolman SR, Dalla-Favera R. Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science. 1984;224:1117\u201321.","journal-title":"Science"},{"key":"656_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ng2025","volume":"39","author":"I Lahortiga","year":"2007","unstructured":"Lahortiga I, De Keersmaecker K, Van Vlierberghe P, Graux C, Cauwelier B, Lambert F, et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet. 2007;39:593\u20135.","journal-title":"Nat Genet"},{"key":"656_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood-2006-12-064683","volume":"110","author":"E Clappier","year":"2007","unstructured":"Clappier E, Cuccuini W, Kalota A, Crinquette A, Cayuela JM, Dik WA, et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood. 2007;110:1251\u201361.","journal-title":"Blood"},{"key":"656_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.stem.2008.11.015","volume":"4","author":"TC Somervaille","year":"2009","unstructured":"Somervaille TC, Matheny CJ, Spencer GJ, Iwasaki M, Rinn JL, Witten DM, et al. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell. 2009;4:129\u201340.","journal-title":"Cell Stem Cell"},{"key":"656_CR38","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1101\/gad.17269211","volume":"25","author":"J Zuber","year":"2011","unstructured":"Zuber J, Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV, et al. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev. 2011;25:1628\u201340.","journal-title":"Genes Dev"},{"key":"656_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/1479-7364-5-4-283","volume":"5","author":"B Jackson","year":"2011","unstructured":"Jackson B, Brocker C, Thompson DC, Black W, Vasiliou K, Nebert DW, et al. Update on the aldehyde dehydrogenase gene (ALDH) superfamily. Hum Genomics. 2011;5:283\u2013303.","journal-title":"Hum Genomics"},{"key":"656_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cbi.2017.06.020","volume":"276","author":"M Gasparetto","year":"2017","unstructured":"Gasparetto M, Smith CA. ALDHs in normal and malignant hematopoietic cells: potential new avenues for treatment of AML and other blood cancers. Chem Biol Interact. 2017;276:46\u201351.","journal-title":"Chem Biol Interact"},{"key":"656_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2820-1","volume":"16","author":"M Flahaut","year":"2016","unstructured":"Flahaut M, Jauquier N, Chevalier N, Nardou K, Balmas Bourloud K, Joseph JM, et al. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma. BMC Cancer. 2016;16:781.","journal-title":"BMC Cancer"},{"key":"656_CR42","doi-asserted-by":"publisher","first-page":"e43664","DOI":"10.1371\/journal.pone.0043664","volume":"7","author":"B Lohberger","year":"2012","unstructured":"Lohberger B, Rinner B, Stuendl N, Absenger M, Liegl-Atzwanger B, Walzer SM, et al. Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma. PLoS ONE. 2012;7:e43664.","journal-title":"PLoS One"},{"key":"656_CR43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.freeradbiomed.2011.11.033","volume":"52","author":"G Muzio","year":"2012","unstructured":"Muzio G, Maggiora M, Paiuzzi E, Oraldi M, Canuto RA. Aldehyde dehydrogenases and cell proliferation. Free Radic Biol Med. 2012;52:735\u201346.","journal-title":"Free Radic Biol Med"},{"key":"656_CR44","doi-asserted-by":"publisher","first-page":"3904645","DOI":"10.1155\/2019\/3904645","volume":"2019","author":"G Vassalli","year":"2019","unstructured":"Vassalli G. Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells. Stem Cells Int. 2019;2019:3904645.","journal-title":"Stem Cells Int"},{"key":"656_CR45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0656-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T05:03:36Z","timestamp":1650171816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0656-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["656"],"URL":"https:\/\/doi.org\/10.1038\/s41375-019-0656-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}